IBM’s 115-Year Record Rout: A $10 Billion Quantum Bet Meets a Mainframe Meltdown
Published on 07/28/2026 at 13:51 | Redaktion boerse-global.de
The numbers are brutal. IBM shares crashed 25.2% in a single day on July 14, the steepest one-day decline in the company’s 115-year history. Nine days later, the stock scraped a new 2026 low of €175.14. From its June all-time high of €292.85, the equity has shed more than a third of its value, currently trading around €191.28 with a modest 0.93% bounce.
The trigger wasn’t a conventional earnings miss. IBM’s second-quarter revenue grew just 1% year-over-year, well below Wall Street expectations. But the real shock came from the mainframe business: sales of the z17 system and related transaction software collapsed 42%. Management acknowledged that corporate clients are aggressively redirecting their IT budgets toward AI-specific hardware — chips, memory, and specialized servers — creating a funding gap that directly hits IBM’s high-margin infrastructure unit.
“The demand is deferred, not destroyed,” CEO Arvind Krishna has argued. The market isn’t buying it. Over the past 30 trading days, IBM shares have fallen roughly 20%, as institutional investors sour on the hybrid-cloud narrative that once underpinned the stock’s premium.
A Strategic Pivot and a $10 Billion Wager
In a move that underscores the company’s shifting priorities, IBM confirmed Monday it had sold over 680 blockchain patent families to Circle. The exit from what was once a core blockchain division marks a clean break from the experimental era of the early 2020s.
Should investors sell immediately? Or is it worth buying IBM?
The new growth bet is quantum computing. In June, IBM announced a $10 billion, five-year investment in its quantum roadmap, targeting “Starling” — what it calls the world’s first large-scale fault-tolerant quantum computer, slated for 2029. This is a long-term wager with no near-term payoff for the current earnings crunch. For patient investors, however, it provides a narrative anchor beyond the 2026 hardware slump.
The company has also trimmed its full-year guidance. IBM now expects constant-currency revenue growth of 4% to 5%, down from the previous forecast of over 5%. Some analysts described the cut as “better than feared,” but the market remains cautious.
Technical Picture and Analyst Views
Technically, the stock is deeply oversold. The relative strength index sits at 36.3, signaling potential for a bounce. From its July low, the share price has recovered about 8%, suggesting value-oriented buyers are defending that floor. Yet IBM remains well below both its 50-day and 200-day moving averages, with no confirmed trend reversal.
The average analyst price target stands at €215.67, implying roughly 13% upside from current levels. That suggests the €177 billion market capitalization may be excessive on the downside — but it also reflects deep uncertainty about when the mainframe and software deals that Krishna calls “deferred” will actually return.
The Core Question: Value Trap or Overreaction?
IBM finds itself in an uncomfortable middle ground. The software segment grew 5% last quarter, but weakness in consulting shows that many enterprises are still building AI infrastructure rather than deploying it productively. The GPU gold rush is starving the very software ecosystem IBM has cultivated for years.
IBM at a turning point? This analysis reveals what investors need to know now.
For the recovery thesis to hold, the company must prove two things: first, that the deferred mainframe and software orders come back once clients finish their initial AI hardware investments; second, that IBM can convert AI pilot projects into recurring software revenue. The free cash flow forecast — a cornerstone of the company’s valuation — will be the key metric to watch.
Until then, the stock remains what it is today: a high-volatility bet on the timing of a cyclical pivot. The probability favors a quiet consolidation phase rather than fresh violent swings. But the market is demanding hard evidence that IBM can coexist with the AI infrastructure wave rather than be consumed by it. For long-term holders, the question is whether this is a classic overreaction or the beginning of a structural decline. The answer won’t come from the chart. It will come from the next few quarters of earnings.
Ad
IBM Stock: New Analysis - 28 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
